Full history for every metric is available with a Kvantra account
Atrion Corporation (ATRI)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 152 | 155 | 148 | 165 | 184 | 169 | 182 |
| Operating profit | $m | 23 | 14 | |||||
| Net profit | $m | 34 | 37 | 32 | 33 | 35 | 19 | 13 |
| EPS reported | $ | 11.02 | 7.14 | |||||
| Operating cashflow per share | $ | 11.36 | 11.36 | |||||
| Capex per share | $ | 12.67 | 12.67 | |||||
| FCF per share | $ | -1.31 | -1.31 | |||||
| Free cash flow | $m | -2 | 28 | |||||
| Net debt | $m | -6 | -18 | |||||
| Book value equity | $m | 243 | 239 | |||||
| Book value per share | $ | 137.9 | 135.5 | |||||
| Number of shares | m | 1.76 | 1.76 | |||||
| DPS (TTM paid) | $ | 8.70 | 8.80 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 34.37 | - | |||||
| P/B LTM | x | 0.00 | 3.39 | |||||
| P/S LTM | x | 0.00 | 4.46 | |||||
| P/FCF LTM | x | -0.29 | 29.24 | |||||
| EV/EBITDA LTM | x | -0.07 | 26.19 | |||||
| EV/Sales LTM | x | -0.02 | 4.36 | |||||
| Earnings Yield LTM | % | 2.91% | 2.40% | |||||
| FCF Yield | % | -346.75% | 3.42% | |||||
| Quality | ||||||||
| ROE | % | 7.99% | 8.05% | |||||
| ROIC | % | 7.89% | 7.89% | |||||
| Operating margin | % | 13.33% | 13.33% | |||||
| Gross margin | % | 36.84% | 36.84% | |||||
| FCF/Sales | % | -1.37% | -1.37% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -43.66% | -53.49% | |||||
| Sales Growth YoY | % | -7.73% | +6.00% | |||||
| Net Income Growth YoY | % | -44.55% | -53.85% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | -13.24% | -40.87% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 2295.3% | 1.91% | |||||
| Dividend Growth | % | +6.10% | - | |||||
| Payout Ratio | % | 78.88% | 123.14% | |||||
| FCF/Debt | x | -9.64 | - | |||||
| Net Debt/EBITDA | x | -0.09 | -0.09 | |||||
| EBIT/Net interest | x | 151.54 | 151.54 | |||||
| Net debt/market cap | % | -901.88% | -2.17% | |||||
| Net debt/Equity | x | -0.02 | -0.07 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Atrion Corporation (ATRI)
Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free